| |
| |
|
| Insider
Information: |
Quart Barry D |
| Relationship: |
|
| City: |
Lafayette |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
187,362 |
|
|
Indirect Shares
|
2,500 |
|
|
| Direct
Value |
$816,692 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
189,862 |
|
|
| Total
Value |
$816,692 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
1
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
1.0
|
| Percentage
Gain/Loss : |
0.0%
|
 4.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Ardea Biosciences Inc |
RDEA |
President and CEO, Dir... |
2012-06-19 |
0 |
2009-05-27 |
2,500 |
Premium* |
|
|
Heron Therapeutics Inc |
HRTX |
Chief Executive Office... |
2023-01-13 |
177,989 |
2016-11-04 |
0 |
Premium* |
|
|
Synageva BioPharma Corp |
GEVA |
|
2014-06-20 |
0 |
2014-06-12 |
0 |
Premium* |
|
|
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-06-06 |
9,373 |
2022-11-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
90 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 4 of 4
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-10-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,768 |
167,005 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-10-13 |
4 |
D |
$3.76 |
$19,623 |
D/D |
(5,219) |
161,786 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2022-10-31 |
4 |
A |
$3.27 |
$5,416 |
D/D |
1,655 |
163,441 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2023-01-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
19,767 |
183,208 |
0 |
- |
|
| HRTX |
Heron Therapeutics Inc |
Chief Executive Officer |
• • – |
2023-01-13 |
4 |
D |
$3.17 |
$16,544 |
D/D |
(5,219) |
177,989 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
|
– • – |
2022-11-29 |
4 |
S |
$16.15 |
$354,638 |
D/D |
(21,959) |
0 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
|
– • – |
2022-11-29 |
4 |
OE |
$1.59 |
$34,915 |
D/D |
21,959 |
21,959 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
|
– • – |
2023-06-29 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,000 |
5,000 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
|
– • – |
2024-06-06 |
4 |
OE |
$0.00 |
$0 |
D/D |
4,373 |
9,373 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
|
– • – |
2014-06-12 |
4 |
OE |
$23.00 |
$23,000 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
|
– • – |
2014-06-12 |
4 |
AS |
$83.31 |
$83,310 |
D/D |
(1,000) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
|
– • – |
2014-06-17 |
4 |
AS |
$90.00 |
$90,000 |
D/D |
(1,000) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
|
– • – |
2014-06-17 |
4 |
OE |
$23.95 |
$23,950 |
D/D |
1,000 |
1,000 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
|
– • – |
2014-06-20 |
4 |
AS |
$100.00 |
$137,500 |
D/D |
(1,375) |
0 |
0 |
- |
|
| GEVA |
Synageva BioPharma Corp |
|
– • – |
2014-06-20 |
4 |
OE |
$25.00 |
$34,375 |
D/D |
1,375 |
1,375 |
0 |
- |
|
90 Records found
|
|
Page 4 of 4 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
